New weekly vs. Bi-Weekly shots tested for stubborn diabetes
NCT ID NCT07055386
Summary
This study is testing two new injection medicines for adults with type 2 diabetes whose blood sugar is still too high despite taking a common class of injectable drugs (GLP-1RAs). Researchers want to see if a weekly shot (GZR102) works as well or better than a shot every two weeks (GZR18) at lowering blood sugar and body weight. The main goal is to find a more convenient and effective option for people struggling to manage their diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site 01
Beijing, China
Conditions
Explore the condition pages connected to this study.